You are here: Industry Insights > Market News > AstraZeneca signs manufacturing pact with Chinese firm, BioKangtai for COVID-19 vaccine

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Retatrutide 2381089-83-2

98% Bifida Ferment Lysate

rhSOD (cosmetic grade)

Recombinant humanized collagen

Recombinant Humanized Small-molecule Collagen

Recombinant Humanized Small-molecule Collagen Solution

AstraZeneca signs manufacturing pact with Chinese firm, BioKangtai for COVID-19 vaccine

expresspharmaAugust 07, 2020

Tag: AstraZeneca , Biokangtai , COVID-19 vaccine

Favorites

AstraZeneca has entered into an agreement with a Chinese vaccine manufacturer BioKangtai to produce 100 million doses of its COVID-19 vaccine candidate AZD1222, when completed, in China by the end of 2020. AstraZeneca is developing this vaccine in a partnership with Oxford University.

The British company announced about this deal through a post on Chinese social platform WeChat.

As per the deal, AstraZeneca will deliver the first 100 million doses this year and 200 million doses by the end of 2021. It also stipulates a commitment for the two firms to explore distributing a vaccine in other markets.

Previous:Xi'an Sanjiang Bio-engineering Co. Ltd.- Exhibitor Webinar

Next:Unichem gets US FDA approval for Tolterodine Tartrate tablets

Xinhua Silk Road: Evaluation report highlights Seoul 120 hotline for its efficient operation

PRNewswireDecember 18, 2024

Seoul 120 hotline has contributed to efficient city operation, according to the Evaluation Report on Worldwide City Hotline Services and Governance Effectiveness (2024) released on Wednesday.

Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of the IND application for the innovative Bi-weekly GLP-1RA GZR18 Injection, Bofanglutide, with chronic weight management Indication (A Phase 2 h

PRNewswireDecember 18, 2024

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Pr

PRNewswireDecember 18, 2024

AstraZeneca signs manufacturing pact with Chinese firm, BioKangtai for COVID-19 vaccine | Pharmasources.com

Pharus Diagnostics LLC Announces Validation of a Laboratory-Developed Test for Early Pancreatic Cancer Detection

PRNewswireDecember 19, 2024

Pharus Diagnostics LLC. (PharusDx), announced a significant step forward in the fight against pancreatic cancer. The company is announcing availability of its OncoSweep™ Pancreas Spotlight

AstraZeneca signs manufacturing pact with Chinese firm, BioKangtai for COVID-19 vaccine

Related News

Xinhua Silk Road: Evaluation report highlights Seoul 120 hotline for its efficient operation

Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of the IND application for the innovative Bi-weekly GLP-1RA GZR18 Injection, Bofanglutide, with chronic weight management Indication (A Phase 2 h

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Pr

Pharus Diagnostics LLC Announces Validation of a Laboratory-Developed Test for Early Pancreatic Cancer Detection

You may like
More>>

AstraZeneca signs manufacturing pact with Chinese firm, BioKangtai for COVID-19 vaccine

Related News

Xinhua Silk Road: Evaluation report highlights Seoul 120 hotline for its efficient operation

Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of the IND application for the innovative Bi-weekly GLP-1RA GZR18 Injection, Bofanglutide, with chronic weight management Indication (A Phase 2 h

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Pr

Pharus Diagnostics LLC Announces Validation of a Laboratory-Developed Test for Early Pancreatic Cancer Detection

You may likeMore>>

You may like
More>>